Melioidosis is an infectious disease with a propensity for relapse, despite prolonged antibiotic eradication therapy for 12 to 20 weeks. A pharmacokinetic (PK) simulation study was performed to determine the optimal dosing of cotrimoxazole (trimethoprim-sulfamethoxazole [TMP-SMX]) used in current eradication regimens in Thailand and Australia. Data for bioavailability, protein binding, and coefficients of absorption and elimination were taken from published literature. Apparent volumes of dis...Expand abstract
- Publication status:
- Publisher copy:
- Copyright date:
Dosing regimens of cotrimoxazole (trimethoprim-sulfamethoxazole) for melioidosis.
If you are the owner of this record, you can report an update to it here: Report update to this record